Review
Published on 27 Apr 2017
FCÎł Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2017.00457
- 14,115 views
- 53 citations
